BRENTWOOD, TENNESSEE / ACCESSWIRE / December 31, 2024 / Odyssey Behavioral Healthcare, a leading provider of mental health, addiction, and eating disorder treatment services, is proud to announce the expansion of its Pasadena Villa Psychiatric Network with the opening of The Grove in Locust Grove, Virginia. The Grove offers residential treatment for adults with primary mental health conditions, addressing a critical need for accessible, high-quality care within the region.
Building on Pasadena Villa’s 25-year legacy of clinical excellence, The Grove marks the fourth residential program, which now spans locations in Tennessee, Michigan, and Virginia. This expansion provides clients with broader access to mental health care and reinforces the network’s commitment to delivering comprehensive, evidence-based treatment.
For clients transitioning from residential treatment, Pasadena Villa offers a fully integrated continuum of care with locations nationwide providing intensive outpatient programs (IOPs) and partial hospitalization programs (PHPs), ensuring ongoing support for sustained recovery.
“Demand for quality mental health treatment continues to rise in Virginia and across the nation,” said Richard Clark, CEO of Odyssey Behavioral Healthcare. “We are proud to address this unmet need by providing superior adult residential treatment at this new mental health location.”
The Grove is now accepting clients and invites the community to tour the facility during its grand opening celebration on Feb. 5. For more information, visit PasadenaVilla.com.
About Odyssey Behavioral Healthcare
Odyssey Behavioral Healthcare, founded in 2015, provides personalized, evidence-based treatment for eating disorders, psychiatric disorders, dual diagnoses, and addiction through a full continuum of residential and intensive outpatient treatment options. For more information on our locations, please click here.
Contact Information
Vicki Smith
Chief Marketing Officer, Odyssey Behavioral Healthcare
vickis@odysseybh.com
615-864-8145
SOURCE: Odyssey Behavioral Healthcare
View the original press release on accesswire.com
Publication of Independent Study Heightens Demand for UroShield ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the…
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical (Nasdaq: ADGM), a leading innovator in catheter ablation technologies for…
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical (Nasdaq: ADGM), a leading innovator in catheter ablation technologies for…
Randomized trial at LSU Health Shreveport will evaluate Seraph 100 Blood Filter's effectiveness in treating…
Stride Expands Across the Midwest, Celebrating its Tenth Center in Iowa and Sixth in Nebraska…
– FDA aligned on plan to initiate parallel Phase 2 trials of rademikibart in patients…
![](data:image/svg+xml;charset=utf-8,<svg height="32px" width="32px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="400px" width="600px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
